122 related articles for article (PubMed ID: 38869944)
21. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
medRxiv; 2021 Dec; ():. PubMed ID: 34909794
[TBL] [Abstract][Full Text] [Related]
23. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Carazo S; Skowronski DM; Brisson M; Barkati S; Sauvageau C; Brousseau N; Gilca R; Fafard J; Talbot D; Ouakki M; Gilca V; Carignan A; Deceuninck G; De Wals P; De Serres G
Lancet Infect Dis; 2023 Jan; 23(1):45-55. PubMed ID: 36152671
[TBL] [Abstract][Full Text] [Related]
24. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
[TBL] [Abstract][Full Text] [Related]
25. Serological Markers of SARS-CoV-2 Reinfection.
Siddiqui SM; Bowman KA; Zhu AL; Fischinger S; Beger S; Maron JS; Bartsch YC; Atyeo C; Gorman MJ; Yanis A; Hultquist JF; Lorenzo-Redondo R; Ozer EA; Simons LM; Talj R; Rankin DA; Chapman L; Meade K; Steinhart J; Mullane S; Siebert S; Streeck H; Sabeti P; Halasa N; Musk ER; Barouch DH; Menon AS; Nilles EJ; Lauffenburger DA; Alter G
mBio; 2022 Feb; 13(1):e0214121. PubMed ID: 35073738
[TBL] [Abstract][Full Text] [Related]
26. Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
Ruff J; Zhang Y; Kappel M; Rathi S; Watkins K; Zhang L; Lockett C
Emerg Infect Dis; 2022 Oct; 28(10):1977-1981. PubMed ID: 35969420
[TBL] [Abstract][Full Text] [Related]
27. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.
Boufidou F; Medić S; Lampropoulou V; Siafakas N; Tsakris A; Anastassopoulou C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629143
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 reinfections during the Delta and Omicron waves.
Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021.
Rosenberg M; Chen C; Golzarri-Arroyo L; Carroll A; Menachemi N; Ludema C
BMC Infect Dis; 2022 Jul; 22(1):592. PubMed ID: 35787250
[TBL] [Abstract][Full Text] [Related]
32. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
[TBL] [Abstract][Full Text] [Related]
34. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.
Flacco ME; Acuti Martellucci C; Baccolini V; De Vito C; Renzi E; Villari P; Manzoli L
Eur J Clin Invest; 2022 Oct; 52(10):e13845. PubMed ID: 35904405
[TBL] [Abstract][Full Text] [Related]
35. Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study.
Atti A; Insalata F; Carr EJ; Otter AD; Castillo-Olivares J; Wu M; Harvey R; Howell M; Chan A; Lyall J; Temperton N; Cantoni D; da Costa K; Nadesalingam A; Taylor-Kerr A; Hettiarachchi N; Tranquillini C; Hewson J; Cole MJ; Foulkes S; Munro K; Monk EJM; Milligan ID; Linley E; Chand MA; Brown CS; Islam J; Semper A; Charlett A; Heeney JL; Beale R; Zambon M; Hopkins S; Brooks T; Hall V;
J Infect; 2022 Nov; 85(5):545-556. PubMed ID: 36089104
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022.
Hall VJ; Insalata F; Foulkes S; Kirwan P; Sparkes D; Atti A; Cole M; de Lacy E; Price L; Corrigan D; Brown CS; Islam J; Charlett A; Hopkins S;
J Infect; 2024 Jan; 88(1):30-40. PubMed ID: 37926119
[TBL] [Abstract][Full Text] [Related]
37. Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination.
Casado JL; Haemmerle J; Vizcarra P; Ramirez-Alonso G; Salazar-Tosco A; Romero-Hernandez B; Blasco M; Rodriguez-Dominguez M; Mirabella IG; Vallejo A; Fernandez-Escribano M
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743421
[TBL] [Abstract][Full Text] [Related]
38. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
Nevejan L; Cuypers L; Laenen L; Van Loo L; Vermeulen F; Wollants E; Van Hecke I; Desmet S; Lagrou K; Maes P; André E
Emerg Infect Dis; 2022 Aug; 28(8):1729-1731. PubMed ID: 35738346
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro.
Penetra SLS; Santos HFP; Resende PC; Bastos LS; da Silva MFB; Pina-Costa A; Lopes RS; Saboia-Vahia L; de Oliveira ACA; Pereira EC; Filho FM; Wakimoto MD; Calvet GA; Fuller TL; Whitworth J; Smith C; Nielsen-Saines K; Carvalho MS; Espíndola OM; Guaraldo L; Siqueira MM; Brasil P
J Infect Dis; 2023 Dec; 228(12):1680-1689. PubMed ID: 37571849
[TBL] [Abstract][Full Text] [Related]
40. Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022.
Bastard J; Taisne B; Figoni J; Mailles A; Durand J; Fayad M; Josset L; Maisa A; van der Werf S; Parent du Châtelet I; Bernard-Stoecklin S
Euro Surveill; 2022 Mar; 27(13):. PubMed ID: 35362406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
